Storys zum Thema Cooperation

Folgen
Keine Story zum Thema Cooperation mehr verpassen.
Filtern
  • 20.12.2012 – 14:00

    High-Tech Bridge SA

    High-Tech Bridge to Partner with Open Security Foundation

    Geneva (ots) - High-Tech Bridge (https://www.htbridge.com/) is pleased to announce its partnership with the Open Security Foundation (OSF) (http://www.opensecurityfoundation.org/) and Open Security Vulnerability Database (OSVDB) (http://www.osvdb.org/)in particular. Ilia Kolochenko, CEO of High-Tech Bridge, says "At High-Tech Bridge, we are pleased to welcome the founders of OSF, Jake Kouns ...

  • 18.12.2012 – 08:03

    Norgine

    Norgine and SpePharm Holding Enter Into Joint Venture

    Amsterdam (ots/PRNewswire) - Norgine BV (Amsterdam) and SpePharm Holding BV (Amsterdam) announced today that they have concluded a broad collaboration agreement under which the two companies have invested in a 50:50 joint venture, SpePharm AG, which has acquired the entire product portfolio of SpePharm Holding, including Savene(R), MuGard(R), Xerotin(R), PROther(R) and the Dantrium(R) brands. The new joint venture will ...

  • 12.12.2012 – 13:44

    UBM Aviation Routes Ltd

    Routes and ALTA Announce Event Collaboration

    Manchester, England (ots/PRNewswire) - Routes and Latin American Airline Association ALTA will partner for Cartagena event The Routes business today announced a partnership with the Latin American and Caribbean Air Transport Association (ALTA), a private, non-profit organization, whose more than 40 member airlines represent over 90 percent of the region's commercial air traffic. ALTA coordinates the collaborative efforts ...

  • 11.12.2012 – 16:35

    Helsinn Healthcare SA

    Palonosetron infusion bag launched in Japan

    Lugano, Switzerland (ots) - The Swiss pharmaceutical Helsinn Group announces today that Taiho Pharmaceutical Co. Ltd., Japanese licensee of Helsinn's second generation 5-HT3 receptor antagonist (5- HT3 RA) palonosetron, has launched on the national market the 0.75mg infusion bag formulation of palonosetron hydrochloride (Aloxi®). The infusion bag is an additional formulation to the 0.75mg injectable form already marketed ...